The Peripheral Intervention Devices Market size was valued at USD 5.3 Billion in 2022 and is projected to reach USD 10.2 Billion by 2030, growing at a CAGR of 8.7% from 2024 to 2030.
The Peripheral Intervention Devices Market is segmented based on the types of medical applications in which these devices are used. Peripheral intervention devices are designed to treat various conditions that affect the peripheral vascular and organ systems. The devices are primarily used to treat non-cardiac diseases, including those related to vascular, oncology, neurology, hepatic, uteral, renal, gastric, and skin procedures. These devices include stents, catheters, balloons, embolization devices, and other specialized instruments that aid in minimally invasive surgeries and interventions. The rapid technological advancements in these devices have led to improved outcomes and shorter recovery times, thereby enhancing the quality of patient care across various treatment fields.
These applications encompass a wide range of procedures that aim to treat specific conditions affecting organs and systems located outside the heart and brain. The growing prevalence of chronic diseases, coupled with an aging population and increased awareness about minimally invasive surgical options, has significantly contributed to the growth of this market. As the demand for such interventions increases, the need for advanced, efficient, and precise peripheral intervention devices continues to rise, making the market highly lucrative for manufacturers, healthcare providers, and patients alike. The key applications in this market include vascular, oncology procedures, neurology, hepatic (liver), uteral, renal, gastric, and skin procedures, each of which is discussed in detail below.
The vascular procedures segment holds a significant share in the peripheral intervention devices market due to the high incidence of vascular diseases, such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and aneurysms. Peripheral intervention devices used in vascular procedures include stents, angioplasty balloons, and catheters designed for minimally invasive treatments. These devices help in restoring blood flow in narrowed or blocked arteries, particularly in the limbs, and are pivotal in managing conditions like PAD, where the arteries become hardened and narrowed. Vascular interventions are vital for preventing amputations and improving patients' quality of life. The growth of this segment is also driven by advancements in device technology, such as drug-eluting stents and the increasing adoption of endovenous laser treatment for varicose veins, which provide better outcomes and reduced complications.
Technological innovations in the vascular devices market are enhancing the precision and safety of vascular interventions, allowing for better management of complex vascular conditions. With the increasing number of people affected by obesity, diabetes, and hypertension, conditions that significantly contribute to vascular diseases, the demand for effective treatment devices continues to surge. Additionally, an increasing focus on minimally invasive techniques and shorter hospital stays is expected to drive further growth in this segment. The development of bioresorbable devices and catheter-based technologies are expected to open new opportunities in the field, providing patients with effective treatments and improving recovery times significantly.
The oncology procedures segment is rapidly growing in the peripheral intervention devices market. Cancer treatments often require localized intervention to manage tumors or block the blood supply to neoplastic growths. In oncology, peripheral intervention devices such as embolization devices, catheters, and drug-eluting stents are used for procedures like transarterial chemoembolization (TACE) and radioembolization. These minimally invasive techniques are primarily used in liver cancer treatments but have expanded to other cancers as well. By selectively targeting tumors, these devices help in controlling the disease, reducing tumor size, and improving the overall prognosis. The use of drug-eluting beads for chemotherapy is becoming more common, offering a highly localized treatment with fewer systemic side effects.
The oncology procedures market is driven by the increasing global cancer burden and a shift toward minimally invasive therapies that offer reduced recovery times and enhanced precision. The rise in demand for interventional oncology techniques, such as image-guided therapies, and the availability of advanced embolization devices are expected to propel the market forward. Moreover, ongoing research into the use of combination therapies involving drug-eluting embolization devices is likely to further enhance treatment efficacy and broaden the range of cancers that can be effectively treated. With growing awareness and technological advancements, the oncology procedures market is poised for significant growth in the coming years.
The neurology procedures segment involves the use of peripheral intervention devices in the treatment of neurological conditions, including brain aneurysms, arteriovenous malformations, and stroke. These procedures are typically performed through minimally invasive techniques, such as endovascular embolization or coiling, where devices like coils, stents, and catheters are used to treat and manage neurological diseases. As stroke incidence rates rise and more people live with neurological conditions, the demand for interventional devices used in treating these diseases continues to grow. Endovascular devices are particularly useful in managing complex cerebral vascular conditions with a high level of precision and minimal patient risk, helping to reduce mortality and disability rates.
Technological advancements, such as 3D imaging and robotic-assisted devices, are revolutionizing the field of neurology interventions. These innovations are helping improve the safety, efficiency, and outcomes of procedures, making them less invasive and more targeted. As a result, the neurology procedures market is experiencing increased adoption of peripheral intervention devices. The continuous evolution of these devices, including stent retrievers and neurovascular catheters, will significantly contribute to the growth of this segment, especially as neurological conditions become more prevalent due to the aging population and lifestyle factors.
Hepatic procedures, which focus on liver diseases such as hepatocellular carcinoma (HCC) and liver cirrhosis, utilize peripheral intervention devices like embolization tools, transarterial chemoembolization (TACE) devices, and catheters. These devices are essential for treating liver tumors and managing complications related to liver diseases. The increasing prevalence of liver diseases, especially with rising alcohol consumption, viral hepatitis, and obesity, is driving the growth of this segment. The use of advanced embolization technologies, such as drug-eluting beads, allows for more targeted and effective treatment, enhancing patient outcomes and minimizing side effects. These devices help in reducing tumor size, controlling liver cancer progression, and improving survival rates.
With advancements in hepatic intervention technologies, the liver procedures segment is witnessing continued growth. The development of non-invasive alternatives, combined with improved imaging techniques, is making these treatments safer and more effective. Furthermore, the growing focus on personalized medicine and combination therapies is expected to boost the demand for peripheral intervention devices in liver disease management. As the number of people diagnosed with liver conditions increases, so too does the need for innovative devices that can provide localized, targeted treatments with minimal risk of complications.
Uteral procedures involve the use of peripheral intervention devices for the treatment of various gynecological conditions, such as uterine fibroids, endometriosis, and obstructed fallopian tubes. In these procedures, devices such as uterine artery embolization (UAE) devices, catheters, and stents are employed to treat and manage these conditions. Uteral interventions, particularly UAE, have become a preferred option for treating fibroids, offering a non-surgical, minimally invasive alternative to hysterectomy. The increasing incidence of uterine conditions, along with the preference for less invasive procedures, is driving the growth of this segment. These devices help in reducing the size of tumors, controlling bleeding, and improving overall reproductive health.
As healthcare providers seek to improve patient outcomes with fewer complications, the demand for uteral intervention devices continues to rise. The focus on minimally invasive procedures, combined with technological advancements in embolization devices and imaging, is expected to drive the segment forward. Additionally, the increasing awareness of the benefits of uteral interventions and the growing trend towards preserving fertility are likely to contribute to the sustained growth of this market segment. As a result, manufacturers are expected to continue developing innovative devices to meet the evolving needs of healthcare professionals and patients.
Renal procedures involve the use of peripheral intervention devices in the management of kidney diseases, including conditions like kidney stones, renal artery stenosis, and renal tumors. Devices such as renal stents, angioplasty balloons, and catheters are commonly used in these procedures to restore kidney function and alleviate symptoms caused by blocked renal arteries or obstructions in the urinary tract. With the rise in chronic kidney disease (CKD) and the increasing number of patients requiring dialysis, the renal procedures segment is expected to continue growing. These devices play a crucial role in improving kidney function and alleviating the burden of dialysis, especially in patients with advanced kidney disease.
Technological advancements in renal intervention devices are improving treatment options for kidney-related conditions. With the rise in hypertension, diabetes, and other risk factors that contribute to kidney disease, the demand for effective renal intervention solutions is increasing. The continued development of minimally invasive procedures, such as percutaneous nephrostomy and renal artery stenting, is expected to drive further market growth. As more patients are diagnosed with kidney disease, the need for innovative devices to manage these conditions will continue to expand, creating significant opportunities for market players.
The gastric procedures segment involves the use of peripheral intervention devices to treat conditions like obesity, gastric cancer, and gastric ulcers. Devices used in these procedures include gastric stents, catheters, and balloons designed to improve digestion, prevent gastric leakage, and aid in the management of obesity through bariatric surgery. As the global obesity epidemic continues to grow, the demand for bariatric interventions and weight-loss devices is increasing. Gastric stents are also used to treat conditions like esophageal or gastric cancer, where they help in alleviating obstructions and improving quality of life for patients. The rise in gastric-related diseases and obesity is driving the growth of this market segment.
With advancements in minimally invasive surgical techniques, including the development of more sophisticated endoscopic and laparoscopic devices, the gastric procedures segment is expected to see continued innovation. These techniques enable quicker recovery, reduced complications, and shorter hospital stays, making them more appealing to both patients and healthcare providers. Furthermore, the increasing prevalence of gastric disorders, including gastric cancer and obesity, is likely to further fuel demand for peripheral intervention devices. The continued evolution of gastric intervention technologies presents significant opportunities for market expansion and device improvement.
The skin procedures segment focuses on the use of peripheral intervention devices for treating dermatological conditions such as skin cancer, burn injuries, and chronic wounds. Devices used in these procedures include skin grafts, wound healing devices, and laser systems for skin regeneration. These devices help in facilitating wound closure, reducing infection, and promoting the regeneration of healthy skin tissue. Skin cancer treatments, including the use of laser-based devices for tumor removal or cryotherapy, are growing due to the increasing prevalence of skin cancer, particularly among the aging population. The demand for these devices is also fueled by the growing awareness of skin health and the increasing need for non-invasive treatments.
As technological advancements continue, the skin procedures segment is poised for growth, with devices becoming more effective and less invasive. Innovations in laser therapy, wound dressings, and advanced skin grafting techniques are improving patient outcomes and reducing recovery times. Furthermore, the rising awareness of skin conditions and the growing demand for aesthetic treatments are expected to continue driving the market forward. Manufacturers are focusing on developing more efficient and user-friendly devices to meet the growing demand for skin-related interventions, thus contributing to the expansion of this segment.
Download In depth Research Report of Peripheral Intervention Devices Market
By combining cutting-edge technology with conventional knowledge, the Peripheral Intervention Devices market is well known for its creative approach. Major participants prioritize high production standards, frequently highlighting energy efficiency and sustainability. Through innovative research, strategic alliances, and ongoing product development, these businesses control both domestic and foreign markets. Prominent manufacturers ensure regulatory compliance while giving priority to changing trends and customer requests. Their competitive advantage is frequently preserved by significant R&D expenditures and a strong emphasis on selling high-end goods worldwide.
Abbott Vascular
Angioscore Ltd.
Cordis Corp.
Boston Scientific
C.R. Bard Inc.
Cook Medical
Medtronic Inc.
Volcano Corporation
Terumo Interventional Systems Inc.
Teleflex Medical
Abbott Vascular
Abbott
W.L.Gore & Associates Ltd.
Bayer
Edward Lifesciences
Medtronic
North America (United States, Canada, and Mexico, etc.)
Asia-Pacific (China, India, Japan, South Korea, and Australia, etc.)
Europe (Germany, United Kingdom, France, Italy, and Spain, etc.)
Latin America (Brazil, Argentina, and Colombia, etc.)
Middle East & Africa (Saudi Arabia, UAE, South Africa, and Egypt, etc.)
For More Information or Query, Visit @ Peripheral Intervention Devices Market Size And Forecast 2024-2030
The peripheral intervention devices market is witnessing a series of key trends, including the adoption of minimally invasive surgical procedures, the development of bioresorbable and drug-eluting devices, and the integration of advanced imaging technologies. These trends are significantly improving treatment outcomes and reducing the risks associated with traditional surgical interventions. Additionally, the growing prevalence of chronic diseases such as cardiovascular conditions, diabetes, and cancer is driving the demand for specialized intervention devices.
Opportunities in the market are abundant, particularly in emerging economies where the demand for advanced healthcare technologies is on the rise. The shift towards outpatient care, coupled with the increasing focus on personalized medicine, is expected to further stimulate the growth of peripheral intervention devices. Manufacturers are also focusing on innovation, with a particular emphasis on developing products that offer improved efficacy, safety, and patient comfort. As the healthcare industry continues to evolve, there will be increasing demand for sophisticated, less invasive devices that can offer precise treatments with shorter recovery times.
What are peripheral intervention devices? Peripheral intervention devices are medical instruments used in minimally invasive procedures to treat conditions affecting the peripheral vascular and organ systems.
How do peripheral intervention devices work in vascular procedures? Peripheral intervention devices, like stents and catheters, help restore blood flow by treating blocked or narrowed arteries in vascular procedures.
Why is there a growing demand for oncology intervention devices? The increasing prevalence of cancer and the shift toward minimally invasive, targeted therapies are driving the demand for oncology intervention devices.
What is the role of peripheral intervention devices in neurology? In neurology, peripheral intervention devices are used to treat neurological conditions like aneurysms and stroke through minimally invasive procedures.
What are the benefits of using embolization devices in hepatic procedures? Embolization devices provide localized treatment for liver cancer by blocking the blood supply to tumors, improving outcomes and reducing side effects.
How do uteral intervention devices help in treating fibroids? Uteral intervention devices, like embolization devices, shrink fibroids, offering a minimally invasive alternative to traditional surgery.
What types of devices are used in renal procedures? Renal procedures often involve the use of stents, catheters, and balloons to treat kidney conditions like stones or renal artery stenosis.
How do gastric procedures benefit from peripheral intervention devices? Gastric procedures use devices like stents and balloons to treat obesity, cancer, and ulcers, improving digestion and reducing complications.
What role do skin procedures play in the market for peripheral intervention devices? Skin procedures use devices like grafts and lasers to treat skin conditions such as burns, cancer, and chronic wounds, enhancing healing and recovery.
What are the future trends for peripheral intervention devices? Future trends include the development of advanced, less invasive devices with enhanced precision and the integration of technologies like robotic assistance and 3D imaging.